Upgrades:
Freeport-McMoRan (NYSE:FCX) was upgraded by equities
research analysts at Citigroup from a “neutral” rating to a “buy” rating in a
report released on Tuesday, The Fly reports. Several other equities analysts
have also commented on FCX. Raymond James set a $16.00 price target on
Freeport-McMoRan and gave the stock a “hold” rating in a research report on
Wednesday, October 24th. ValuEngine lowered Freeport-McMoRan from a “sell” rating
to a “strong sell” rating in a research report on Wednesday, October 24th. BMO
Capital Markets set a $13.00 price target on Freeport-McMoRan and gave the
stock a “hold” rating in a research report on Thursday, October 25th. B. Riley
cut their target price on Freeport-McMoRan from $18.00 to $16.00 and set a
“buy” rating on the stock in a research report on Thursday, October 25th.
Finally, Royal Bank of Canada lowered Freeport-McMoRan from a “sector perform”
rating to an “underperform” rating and set a $12.20 target price on the stock.
in a research report on Tuesday, November 6th. They noted that the move was a
valuation call. Three research analysts have rated the stock with a sell
rating, eleven have issued a hold rating and seven have issued a buy rating to
the stock. The stock has a consensus rating of “Hold” and a consensus price
target of $16.15. Read more …
Macquarie upgraded shares of PepsiCo (NASDAQ:PEP) from a
neutral rating to an outperform rating in a report published on Tuesday,
MarketBeat reports. The brokerage currently has $126.00 price target on the
stock. PEP has been the subject of a number of other reports. BidaskClub raised
shares of PepsiCo from a hold rating to a buy rating in a research note on
Friday, October 26th. Zacks Investment Research reaffirmed a sell rating on
shares of PepsiCo in a research note on Wednesday, November 14th. Jefferies
Financial Group upped their price objective on shares of PepsiCo to $119.00 and
gave the company a hold rating in a research note on Tuesday. They noted that
the move was a valuation call. Finally, UBS Group initiated coverage on shares
of PepsiCo in a research note on Thursday, December 13th. They set a neutral
rating and a $123.00 price objective for the company. One analyst has rated the
stock with a sell rating, thirteen have given a hold rating and six have given
a buy rating to the stock. The stock currently has a consensus rating of Hold
and an average target price of $119.83. Read more …
Intel (NASDAQ:INTC) was upgraded by research analysts at
Morgan Stanley from an “equal weight” rating to an “overweight” rating in a
research note issued on Friday, The Fly reports. The brokerage presently has a
$64.00 price objective on the chip maker’s stock, up from their prior price
objective of $55.00. Morgan Stanley’s target price indicates a potential upside
of 21.77% from the stock’s previous close. Several other research analysts have
also recently weighed in on INTC. BidaskClub cut shares of Intel from a “buy”
rating to a “hold” rating in a research note on Thursday, January 17th. Royal
Bank of Canada reiterated a “neutral” rating and set a $55.00 price target on
shares of Intel in a research note on Wednesday, January 23rd. Nomura
reiterated a “buy” rating and set a $55.00 price target on shares of Intel in a
research note on Wednesday, November 7th. Citigroup reiterated a “buy” rating
and set a $54.00 price target (up previously from $50.00) on shares of Intel in
a research note on Friday, January 11th. Finally, Goldman Sachs Group
reiterated a “sell” rating and set a $44.00 price target on shares of Intel in
a research note on Tuesday, January 8th. Six analysts have rated the stock with
a sell rating, fourteen have assigned a hold rating and nineteen have issued a
buy rating to the stock. The company currently has a consensus rating of “Hold”
and an average target price of $53.65. Read more …
Downgrades:
Norfolk Southern (NYSE:NSC) was downgraded by investment
analysts at Royal Bank of Canada from a “sector perform” rating to an
“underperform” rating in a report released on Tuesday, Marketbeat reports. They
currently have a $178.00 price target on the railroad operator’s stock, down
from their prior price target of $180.00. Royal Bank of Canada’s price
objective would suggest a potential downside of 2.13% from the stock’s previous
close. A number of other equities analysts have also recently issued reports on
NSC. ValuEngine upgraded shares of Norfolk Southern from a “hold” rating to a
“buy” rating in a research report on Tuesday, February 12th. Zacks Investment
Research upgraded shares of Norfolk Southern from a “hold” rating to a “buy”
rating and set a $191.00 price objective on the stock in a research report on
Wednesday, November 21st. Credit Suisse Group boosted their price objective on
shares of Norfolk Southern from $181.00 to $195.00 and gave the company an
“outperform” rating in a research report on Tuesday, February 12th. Loop
Capital boosted their price objective on shares of Norfolk Southern to $210.00
and gave the company a “buy” rating in a research report on Monday, February
11th. Finally, BMO Capital Markets boosted their price objective on shares of
Norfolk Southern to $185.00 and gave the company a “market perform” rating in a
research report on Tuesday, February 12th. Two investment analysts have rated
the stock with a sell rating, eight have assigned a hold rating and twelve have
given a buy rating to the company’s stock. The company presently has an average
rating of “Hold” and a consensus price target of $183.62. Read more …
NESTLE S A/S (OTCMKTS:NSRGY) was downgraded by stock
analysts at Royal Bank of Canada from an “outperform” rating to a “sector
perform” rating in a research note issued to investors on Tuesday, The Fly
reports. Other analysts also recently issued research reports about the
company. Zacks Investment Research downgraded NESTLE S A/S from a “hold” rating
to a “sell” rating in a research report on Saturday, February 2nd. JPMorgan
Chase & Co. set a $100.00 price objective on NESTLE S A/S and gave the
stock a “buy” rating in a research report on Monday, December 10th. UBS Group
upgraded NESTLE S A/S from a “neutral” rating to a “buy” rating in a research
report on Thursday, January 3rd. Societe Generale assumed coverage on NESTLE S
A/S in a research report on Tuesday, January 29th. They issued a “buy” rating
for the company. Finally, Berenberg Bank upgraded NESTLE S A/S from a “hold”
rating to a “buy” rating in a research report on Thursday, January 24th. One
analyst has rated the stock with a sell rating, three have assigned a hold
rating and six have issued a buy rating to the company. NESTLE S A/S currently
has an average rating of “Buy” and an average price target of $96.50. Read more…
Occidental Petroleum (NYSE:OXY) was downgraded by stock
analysts at Citigroup from a “buy” rating to a “neutral” rating in a research
note issued to investors on Tuesday, The Fly reports. A number of other
equities research analysts have also weighed in on OXY. Raymond James raised
Occidental Petroleum from an “outperform” rating to a “strong-buy” rating in a
research report on Monday, October 22nd. They noted that the move was a valuation
call. ValuEngine lowered Occidental Petroleum from a “hold” rating to a “sell”
rating in a research report on Friday, November 2nd. Morgan Stanley decreased
their target price on Occidental Petroleum from $100.00 to $96.00 and set a
“buy” rating for the company in a research report on Monday, November 5th.
Evercore ISI raised Occidental Petroleum from an “in-line” rating to an
“outperform” rating and set a $88.00 target price for the company in a research
report on Wednesday, November 7th. Finally, Barclays started coverage on
Occidental Petroleum in a research report on Monday, November 12th. They set an
“overweight” rating and a $84.00 target price for the company. Two analysts
have rated the stock with a sell rating, nine have assigned a hold rating, thirteen
have given a buy rating and one has assigned a strong buy rating to the
company’s stock. The stock currently has an average rating of “Buy” and a
consensus target price of $84.53. Read more …
CVS Health (NYSE:CVS) was downgraded by equities researchers
at Wells Fargo & Co from an “outperform” rating to a “market perform”
rating in a note issued to investors on Wednesday, The Fly reports. A number of
other equities analysts have also recently weighed in on the stock. Tigress
Financial reaffirmed a “buy” rating on shares of CVS Health in a research
report on Friday, October 26th. Cantor Fitzgerald reaffirmed a “buy” rating and
set a $96.00 price objective on shares of CVS Health in a research report on
Thursday, January 3rd. Wolfe Research initiated coverage on shares of CVS
Health in a research report on Thursday, October 25th. They set a “peer
perform” rating for the company. Bank of America reaffirmed a “buy” rating and
set a $92.00 price objective on shares of CVS Health in a research report on
Thursday, January 3rd. Finally, ValuEngine cut shares of CVS Health from a
“sell” rating to a “strong sell” rating in a research report on Thursday,
January 17th. One analyst has rated the stock with a sell rating, three have
given a hold rating and twelve have assigned a buy rating to the stock. The
stock currently has an average rating of “Buy” and an average price target of
$91.79. Read more …
Ecolab (NYSE:ECL) was downgraded by stock analysts at
JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a
report released on Wednesday, The Fly reports. Other equities analysts also
recently issued reports about the company. Bank of America started coverage on
Ecolab in a report on Tuesday, October 23rd. They issued a “buy” rating and a
$123.00 price objective on the stock. Boenning Scattergood restated a “buy”
rating and issued a $210.00 price objective on shares of Ecolab in a report on
Tuesday, February 5th. Zacks Investment Research upgraded Ecolab from a “sell”
rating to a “hold” rating in a report on Wednesday, November 21st. Deutsche
Bank raised their price objective on Ecolab from $150.00 to $162.00 and gave
the stock a “hold” rating in a report on Monday, November 5th. Finally, BMO
Capital Markets raised their price objective on Ecolab from $151.00 to $159.00
and gave the stock a “hold” rating in a report on Thursday, November 1st. One
research analyst has rated the stock with a sell rating, nine have issued a
hold rating and six have issued a buy rating to the company. Ecolab currently
has a consensus rating of “Hold” and an average target price of $159.36. Read more …
Southwest Airlines (NYSE:LUV) was downgraded by investment
analysts at Goldman Sachs Group to a “sell” rating in a research report issued
to clients and investors on Wednesday, The Fly reports. LUV has been the topic
of a number of other research reports. Macquarie set a $65.00 price target on
shares of Southwest Airlines and gave the company a “buy” rating in a research
note on Tuesday, January 29th. Imperial Capital decreased their price target on
shares of Southwest Airlines from $66.00 to $56.00 and set an “in-line” rating
on the stock in a research note on Friday, October 26th. Wolfe Research
upgraded shares of Southwest Airlines from a “market perform” rating to an
“outperform” rating in a research report on Friday, December 7th. Zacks
Investment Research upgraded shares of Southwest Airlines from a “hold” rating
to a “buy” rating and set a $57.00 price objective on the stock in a research
report on Wednesday, January 23rd. Finally, Morgan Stanley cut their price
objective on shares of Southwest Airlines from $68.00 to $64.00 and set an
“overweight” rating on the stock in a research report on Wednesday, November
14th. Two investment analysts have rated the stock with a sell rating, six have
issued a hold rating and fifteen have given a buy rating to the company. The
stock currently has a consensus rating of “Buy” and an average price target of
$62.22. Read more …
D. R. Horton (NYSE:DHI) was downgraded by analysts at
Wedbush from an “outperform” rating to a “neutral” rating in a research note
issued to investors on Thursday, The Fly reports. A number of other equities
analysts also recently commented on DHI. ValuEngine raised D. R. Horton from a
“sell” rating to a “hold” rating in a research report on Wednesday, February
13th. Raymond James downgraded D. R. Horton from a “strong-buy” rating to a
“market perform” rating and set a $39.43 price objective for the company. in a
research report on Thursday, February 14th. Credit Suisse Group set a $46.00
price objective on D. R. Horton and gave the stock a “buy” rating in a research
report on Friday, February 15th. Buckingham Research initiated coverage on D.
R. Horton in a research report on Friday, January 11th. They set a “buy” rating
for the company. Finally, Keefe, Bruyette & Woods downgraded D. R. Horton
from an “outperform” rating to a “market perform” rating in a research report
on Friday, January 11th. Seven analysts have rated the stock with a hold rating
and ten have given a buy rating to the company’s stock. D. R. Horton has an
average rating of “Buy” and a consensus target price of $46.32. Read more …
General Mills (NYSE:GIS) was downgraded by analysts at
Standpoint Research from a “buy” rating to a “hold” rating in a research report
issued on Thursday. GIS has been the subject of a number of other reports.
Credit Suisse Group dropped their price objective on General Mills from $46.00
to $41.00 and set a “neutral” rating for the company in a research note on
Thursday, December 20th. Jefferies Financial Group set a $55.00 price objective
on General Mills and gave the company a “buy gis” rating in a research note on
Monday, December 24th. Bank of America reissued a “neutral” rating and set a
$45.00 target price (down from $49.00) on shares of General Mills in a research
note on Friday, December 7th. Morgan Stanley set a $41.00 target price on
General Mills and gave the stock a “hold” rating in a research note on Friday,
December 21st. Finally, UBS Group reissued a “buy” rating and set a $40.00
target price on shares of General Mills in a research note on Friday, December
14th. Two equities research analysts have rated the stock with a sell rating,
fourteen have assigned a hold rating and five have given a buy rating to the
company’s stock. The stock has a consensus rating of “Hold” and an average
target price of $47.45. Read more …
Valero Energy (NYSE:VLO) was downgraded by equities
researchers at Standpoint Research from a “buy” rating to a “hold” rating in a
research note issued on Thursday, The Fly reports. A number of other research
firms have also weighed in on VLO. Macquarie raised shares of Valero Energy
from a “neutral” rating to an “outperform” rating and set a $81.20 target price
for the company in a research report on Friday, January 18th. Piper Jaffray
Companies restated an “overweight” rating on shares of Valero Energy in a
report on Thursday, January 10th. Zacks Investment Research upgraded shares of
Valero Energy from a “strong sell” rating to a “hold” rating in a report on
Saturday, January 5th. Argus set a $110.00 price objective on shares of Valero
Energy and gave the stock a “buy” rating in a report on Tuesday, February 5th.
Finally, Morgan Stanley dropped their price objective on shares of Valero
Energy from $135.00 to $110.00 and set a “buy” rating on the stock in a report
on Tuesday, November 20th. One investment analyst has rated the stock with a
sell rating, ten have issued a hold rating and eleven have issued a buy rating
to the company. Valero Energy currently has a consensus rating of “Hold” and a
consensus target price of $112.01. Read more …
GlaxoSmithKline (LON:GSK) was downgraded by UBS Group to a
“neutral” rating in a research report issued to clients and investors on
Friday, investing.thisismoney.co.uk reports. They currently have a GBX 1,650
($21.56) price objective on the stock, down from their prior price objective of
GBX 1,700 ($22.21). UBS Group’s price objective would indicate a potential
upside of 8.01% from the company’s previous close. A number of other research
analysts also recently weighed in on the company. Deutsche Bank set a GBX 1,520
($19.86) price objective on GlaxoSmithKline and gave the company a “neutral”
rating in a research note on Tuesday, February 12th. Barclays reissued an
“equal weight” rating on shares of GlaxoSmithKline in a research note on
Friday, February 8th. Kepler Capital Markets set a GBX 1,440 ($18.82) price
objective on GlaxoSmithKline and gave the company a “neutral” rating in a
research note on Thursday, February 7th. Credit Suisse Group set a GBX 1,600
($20.91) price objective on GlaxoSmithKline and gave the company a “neutral”
rating in a research note on Thursday, February 7th. Finally, HSBC raised their
price objective on GlaxoSmithKline from GBX 1,820 ($23.78) to GBX 1,860
($24.30) and gave the company a “buy” rating in a research note on Thursday,
February 7th. Two investment analysts have rated the stock with a sell rating,
eleven have assigned a hold rating and five have assigned a buy rating to the
stock. The company has a consensus rating of “Hold” and a consensus price
target of GBX 1,518.15 ($19.84). Read more …
Kraft Heinz (NASDAQ:KHC) was downgraded by investment
analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral”
rating in a note issued to investors on Friday, The Fly reports. Several other
brokerages also recently weighed in on KHC. Royal Bank of Canada decreased
their price target on Kraft Heinz to $68.00 and set an “outperform” rating for
the company in a report on Friday, November 2nd. Standpoint Research initiated
coverage on Kraft Heinz in a report on Wednesday, December 26th. They set a
“buy” rating for the company. Deutsche Bank downgraded Kraft Heinz from a “buy”
rating to a “hold” rating and decreased their price target for the stock from
$58.00 to $52.00 in a report on Tuesday, February 5th. Zacks Investment
Research raised Kraft Heinz from a “sell” rating to a “hold” rating in a report
on Wednesday, February 13th. Finally, BidaskClub downgraded Kraft Heinz from a
“hold” rating to a “sell” rating in a report on Tuesday, November 20th. Six
investment analysts have rated the stock with a sell rating, ten have given a
hold rating and six have given a buy rating to the company’s stock. Kraft Heinz
has a consensus rating of “Hold” and an average target price of $63.15. Readmore …
Comments
Post a Comment